نتایج جستجو برای: 3a5 cpy

تعداد نتایج: 371  

Journal: :Anesthesiology 2005
Theresa Mariero Klees Pamela Sheffels Kenneth E Thummel Evan D Kharasch

BACKGROUND There is considerable unexplained interindividual variability in the clearance of alfentanil. Alfentanil undergoes extensive metabolism by cytochrome P4503A4 (CYP3A4). CYP3A5 is structurally similar to CYP3A4 and metabolizes most CYP3A4 substrates but is polymorphically expressed. Livers with the CYP3A5*1 allele contain higher amounts of the native CYP3A5 protein than livers homozygo...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2004
Donavon J McConn Yvonne S Lin Kyle Allen Kent L Kunze Kenneth E Thummel

The objectives of this study were to characterize and compare the reversible inhibition and time-dependent inactivation of cytochromes P450 3A4 and 3A5 (CYP3A4 and CYP3A5) by erythromycin, diltiazem, and nicardipine. In the following experiments, we used cDNA-expressed CYP3A Supersomes and CYP3A-phenotyped human liver microsomes. We estimated the apparent constants for reversible inhibition (Ki...

2016
David J. Kopsky

The last 2 decades more and more attention has been given to topical analgesia. Peripheral nerves in the epidermis are influenced by topical analgesics with the aim to reduce neuropathic pain. Systemic side effects are rare, because the purpose of topical analgesics is not to penetrate deeper than the epidermis. Thus topical analgesics are particularly beneficial in the treatment of geriatric p...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2007
H F Perrett Z E Barter B C Jones H Yamazaki G T Tucker A Rostami-Hodjegan

An analysis of reported hepatic abundances of CYP3A4 and 3A5 indicated that values determined by immunoquantification using commercially available, unpurified recombinant enzymes as standards are significantly lower than those determined using purified enzymes or human liver microsomes characterized with lysosomal peptides (CYP3A4: mean 45 versus 121 pmol/mg protein, p < 0.01; CYP3A5: mean 28 v...

2010

Clonidine is a centrally acting, -2 adrenergic agonist used for the treatment of hypertension during pregnancy. The metabolic pathways of clonidine are poorly understood, and the quantitative contribution of specific human cytochrome P450 (P450) isoforms has not been systematically assessed. In this study, 17 cDNA-expressed P450 enzymes, in addition to pooled human liver microsomes, were evalua...

2016
D Zhou K Bui M Sostek N Al‐Huniti

Naloxegol, a peripherally acting μ-opioid receptor antagonist for the treatment of opioid-induced constipation, is a substrate for cytochrome P450 (CYP) 3A4/3A5 and the P-glycoprotein (P-gp) transporter. By integrating in silico, preclinical, and clinical pharmacokinetic (PK) findings, minimal and full physiologically based pharmacokinetic (PBPK) models were developed to predict the drug-drug i...

Journal: :Plant physiology 1986
F X Cunningham J A Schiff

The use of n-octyl-beta-d-glucopyranoside along with sodium dodecyl sulfate improves the retention of chlorophyll (Chl) by chlorophyll-protein complexes (CPs) prepared from thylakoids of Euglena gracilis Klebs var bacillaris Cori and yields several additional complexes. Thylakoids from wild-type (WT) cells, solubilized in these detergents and subjected to polyacrylamide gel electrophoresis at 0...

Journal: :Cell 2001
Esteban C. Dell'Angelica Gregory S. Payne

the TGN and ligand delivery to lysosomes. Deficiencies in both MPRs, or in addition of the mannose 6-phosphate tag, result in massive secretion of lysosome enzyme precursors into the extracellular milieu. In the yeast Saccharomyces cerevisiae, an analogous receptor-mediated pathway transports soluble hy-Los Angeles, California 90095 drolases to the lysosome-like vacuole, although sorting recept...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2011
Hsia-lien Lin Haoming Zhang Christine Medower Paul F Hollenberg William W Johnson

An investigational anticancer agent that contains a thiophene moiety, 3-[(quinolin-4-ylmethyl)-amino]-N-[4-trifluoromethox)phenyl] thiophene-2-carboxamide (OSI-930), was tested to investigate its ability to modulate the activities of several cytochrome P450 enzymes. Results showed that OSI-930 inactivated purified, recombinant cytochrome P450 (P450) 3A4 in the reconstituted system in a mechanis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید